Re: MNKD's Market Cap Is Currently At $1.124B - See If It Goes Up After Tomorrow's Financials
Mike C better show up with the goods. We have been stuck in this range for far too long and the main reason is his "rest and grow" strategy.
I will say he was dealt a crap hand again by the FDA with Tyvaso DPI. First the trial being delayed because of Covid and then the FDA hosing UTHR in Oct 2021 and again in Feb 2022.
We need to see good quarterly numbers and at least give us some guidance. It would be nice to get another compound funded or a partner deal with Afrezza.
Time for Mike to "DELIVER" and hoping it starts tomorrow.